Pure Global
NCT06319508

Stellate Ganglion Block in Cerebral Palsy

A Randomized Controlled Study to Explore The Effect of Stellate Ganglion Block in Cerebral Palsy and Dysphagia
Copka Sonpashan·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cerebral Palsy
Drug/Device/Intervention
routine rehabilitation treatment
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Copka Sonpashan
Funder
Chao Phya Abhaibhubejhr Hospital
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Dec 01, 2024
Enrollment
80 participants
Primary outcome

Penetration-Aspiration Scale

Summary

The goal of this clinical trial is to test the efficacy of stellate ganglion block in
 children with cerebral palsy and dysphagia. The main question it aims to answer are:
 
 • Can stellate ganglion block improve the dysphagia of children with cerebral palsy?
 Participants were randomly divided into two groups, all provided with routine therapy. Based
 on this, the experimental group was given stellate ganglion block. The video fluoroscopic
 swallowing study was done to test the swallowing function before and after the study.

ICD-10 classifications
Cerebral palsyOther cerebral palsyCerebral palsy, unspecifiedDyskinetic cerebral palsyAtaxic cerebral palsy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06319508
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06319508 through Pure Global AI's free database. This phase not specified trial is sponsored by Copka Sonpashan and is currently Not yet recruiting. The study focuses on Cerebral Palsy. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.